The diagnostic relevance of Lewy bodies and other inclusions in Parkinson’s disease

  • W. R. G. Gibb
Part of the Key Topics in Brain Research book series (KEYTOPICS)


Seventy-four of 78 patients with Parkinson’s disease (PD) had Lewy bodies in the substantia nigra. Two without Lewy bodies had striatonigral degeneration and two had post-encephalitic pathology. Lewy bodies in controls occurred in 3.6% to 11.1% between the sixth and tenth decades, and similar figures were obtained in other common parkinsonian disorders and Alzheimer’s disease. Lewy bodies can also occur in corticobasal degeneration and Hallervorden-Spatz disease. The pathological diagnosis of PD depends on finding Lewy bodies in the substantia nigra, but other parkinsonian disorders must be excluded.


Substantia Nigra Multiple System Atrophy Lewy Body Lewy Body Disease Corticobasal Degeneration 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Beheim-Schwarzbach D (1952) Über Zelleibveränderungen im Nucleus coeruleus bei Parkinsonian-Symptomen. J Nerv Ment Dis 116: 619–632PubMedCrossRefGoogle Scholar
  2. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20: 415–455PubMedCrossRefGoogle Scholar
  3. Forno LS (1966) Pathology ofparkinsonism. A preliminary report of24 cases. J Neurosurg [Suppl] 24: 266–271Google Scholar
  4. Gibb WRG (1986) Idiopathic Parkinson’s disease and the Lewy body disorders. Neuropath Appl Neurobiol 12: 223–234CrossRefGoogle Scholar
  5. Gibb WRG, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body. disease ( Lewy body dementia ). Brain 110: 1131–1153PubMedCrossRefGoogle Scholar
  6. Gibb WRG, Luthert PJ, Marsden CD (1988) Corticobasal degeneration. Brain (in press)Google Scholar
  7. Greenfield JG, Bosanquet FD (1953) The brain-stem lesions in Parkinson-ism. J Neurol Neurosurg Psychiatr 16: 213–226PubMedCrossRefGoogle Scholar
  8. Hirano A (1973) Progress in the pathology of motor neuron diseases. In: Zimmerman HM (ed) Progress in neuropathology. Grune and Stratton, London, pp 181–215Google Scholar
  9. Pakkenberg H, Brody H (1965) The number of nerve cells in the substantia nigra in paralysis agitans. Acta Neuropathol 5: 320–324PubMedCrossRefGoogle Scholar
  10. Popovitch ER, Wisniewski HM, Kaufmann MA, Grundke-Iqbal I, Wen GY (1987) Young adult-form of dementia with neurofibrillary changes and Lewy bodies. Acta Neuropathol 74: 97–104PubMedCrossRefGoogle Scholar
  11. Rajput AH, Rozdilsky B, Hornykiewicz O, Shannak K, Lees T, Seeman P (1982) Reversible drug-induced parkinsonism. Clinicopathological study of two cases. Arch Neurol 39: 644–646PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1989

Authors and Affiliations

  • W. R. G. Gibb
    • 1
  1. 1.Department of NeuropathologyNational Hospitals for Nervous DiseasesLondon W9UK

Personalised recommendations